"Western Data Have Limits... Korean Cohorts Are Redefining Brain Disease Standards"
Differences in Amyloid Accumulation Patterns Between Koreans and Westerners
Brain Disease Risk Factors Vary by Gender
Long-term Follow-up of 12,000 Stroke Patients
Provides Evidence for Rehabilitation Policy
Long-term cohort data reflecting the characteristics of Koreans are emerging as a core foundation for precision medicine in dementia and stroke. Since risk factors for brain diseases, disease progression rates, and treatment responses differ from those of Western populations, experts emphasize that diagnostic and treatment standards tailored for Koreans should be established based on data from long-term follow-up of domestic patients.
Go Young-ho, Head of the Brain Disease Research Department at the National Institute of Health, stated at a media seminar titled "Data: Reading the Brain, Connecting Lives" hosted by the National Institute of Health and the Korea Science Journalists Association at the HJ Business Center in Jung-gu, Seoul, on the 15th, "We must reinterpret overseas guidelines through the lens of cohort studies specific to Koreans to establish an individualized prevention system."
Goh Young-ho, Head of the Brain Disease Research Division at the National Institute of Health, is speaking at the media seminar hosted by the National Institute of Health and the Korea Science Journalists Association held on the 15th at HJ Business Center in Jung-gu, Seoul. Korea Science Journalists Association
View original imageThe National Institute of Health has been linking and tracking four brain disease cohorts—including early-onset dementia, senile dementia, local community high-risk groups, and Parkinson’s disease—since 2021. The institute is currently standardizing and integrating clinical and epidemiological data, along with genomic, imaging, and blood biomarker information, gathered from 49 hospitals, into a comprehensive database. Go explained, "There is no such thing as an average patient when it comes to brain diseases. Among Koreans, unique tendencies were observed: for women, obesity, hypertension, and diabetes have a significant impact on brain atrophy, while for men, the influence of being underweight stands out."
Seo Sangwon, Professor in the Department of Neurology at Samsung Medical Center, pointed out, "The proportion of cognitively normal individuals with amyloid protein accumulation in the brain is about 30% among Westerners, while it stands at approximately 20% for Koreans. However, once amyloid starts to accumulate, cognitive decline appears to progress more rapidly among Koreans." He added, "Instead of applying foreign standards as they are, we need precision prevention strategies tailored to Koreans that also take gender differences into account."
Alzheimer’s disease can undergo pathological changes 10 to 20 years before symptoms appear, making early screening crucial. Professor Seo explained that MRI, PET scans, genomic data, blood biomarkers, and cognitive tests need to be accumulated over the long term in the same individual in order to establish baseline and diagnostic criteria relevant to Koreans. As blood biomarkers begin to partially replace costly PET scans, barriers to precision diagnosis are also expected to become lower.
Professor Sangwon Seo, Department of Neurology at Samsung Medical Center, is speaking at a media seminar hosted by the National Institute of Health and the Korean Science Journalists Association, held on the 15th at the HJ Business Center in Jung-gu, Seoul. Korean Science Journalists Association
View original imageLong-term cohorts are also broadening the goals of stroke treatment from mere 'survival' to 'restoration of life.' Since 2012, the National Institute of Health has been tracking over 12,000 stroke patients for up to 14 years, analyzing motor, cognitive, and language functions, quality of life, and caregiving burdens. The accumulated data serve as evidence for health care policies such as clinical practice guidelines for stroke rehabilitation and reimbursement standards for early intensive rehabilitation.
Jang Wonhyuk, Professor of Rehabilitation Medicine at Samsung Medical Center, revealed, "According to the primary cohort analysis, the 10-year cumulative mortality rate for first-time stroke patients in Korea was estimated at 41.1%. The functions of survivors can recover up to two years after onset, but there is a trend toward decline again after seven to nine years." Professor Jang stressed the need for a management system that extends beyond acute-phase treatment to include chronic-phase care and community-integrated care. Kim Daehyun, Professor of Rehabilitation Medicine at Samsung Medical Center, also commented, "In studies on intensive intervention involving exercise, language, nutrition, and education, treatments tailored to patients' conditions helped improve both functional recovery and quality of life."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Go added, "The more cohort data is accumulated both over time and with greater accuracy, the more research on brain diseases will evolve beyond simple prediction to personalized prevention, treatment, and management."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.